Text Size
50 studies found for:    Alkermes

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)
Condition: Alcohol Dependence
Interventions: Drug: Medisorb naltrexone 190 mg;   Drug: Medisorb naltrexone 380 mg
2 Completed
Has Results 		ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults
Condition: Alcoholism
Interventions: Drug: Medisorb naltrexone 380 mg;   Drug: Medisorb naltrexone 190 mg
3 Terminated
Has Results 		ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])
Conditions: Alcoholism;   Opiate Dependence
Interventions: Drug: Medisorb naltrexone 380 mg;   Drug: Oral naltrexone to Medisorb naltrexone 380 mg
4 Active, not recruiting A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Interventions: Drug: ALKS 5461;   Drug: Placebo
5 Recruiting A Study to Evaluate the Efficacy and Safety of ALKS 9072 in Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ALKS 9072;   Drug: Placebo
6 Completed ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)
Condition: Opioid-induced Constipation
Interventions: Drug: RDC-1036 (ALKS 37);   Drug: Placebo
7 Completed ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals
Condition: Opiate Dependence
Intervention: Drug: Medisorb naltrexone 380 mg
8 Completed ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)
Condition: OIC
Interventions: Drug: ALKS 37;   Drug: Placebo
9 Completed ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)
Condition: Opioid-induced Constipation
Interventions: Drug: ALKS 37;   Drug: Placebo
10 Recruiting A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
Condition: Schizophrenia
Interventions: Drug: ALKS 9072, Low;   Drug: ALKS 9072, High
11 Recruiting A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ALKS 9072, Low dose;   Drug: ALKS 9072, Med dose;   Drug: ALKS 9072, High dose;   Drug: Placebo
12 Completed ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
Condition: Binge Eating Disorder
Interventions: Drug: RDC-0313 (ALKS 33);   Drug: Placebo
13 Completed ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine
Condition: Cocaine Abuse
Interventions: Drug: ALKS 33-BUP;   Drug: ALKS 33;   Drug: Placebo
14 Recruiting A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Condition: Opioid Dependence
Intervention: Drug: VIVITROL 380mg
15 Completed ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence
Condition: Alcohol Dependence
Interventions: Drug: ALKS33 (RDC-0313) (1 mg);   Drug: ALKS33 (RDC-0313) (2.5 mg);   Drug: ALKS33 (RDC-0313) (10 mg);   Drug: Placebo
16 Completed Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
Conditions: Diabetes Mellitus;   Asthma;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: injected insulin
17 Completed Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Injectable Insulin;   Drug: Insulin Glargine
18 Completed Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Injectable insulin
19 Completed Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Insulin Glargine
20 Completed Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Insulin Glargine
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years